Pharmacovigilance Awareness for Non-PV Staff
yashfin
Course Overview
Pharmacovigilance Awareness for Non-PV Staff is a self-paced, interactive e-learning course designed to build essential drug safety awareness across all functions of a pharmaceutical, biotech, or life sciences organisation. The course demystifies pharmacovigilance — a discipline often perceived as the exclusive domain of specialist teams — and equips every employee with the knowledge and practical skills needed to recognise, handle, and escalate medicine safety information correctly.Grounded in globally applicable regulatory frameworks (including WHO, ICH, and GVP guidelines), the course uses real-world scenarios, case studies drawn from landmark PV failures, and interactive exercises to bring compliance to life. Learners progress through five substantive modules covering the history and science of PV, key terminology, individual reporting obligations, signal detection, risk management, and emerging areas such as digital pharmacovigilance and biologics. The course concludes with a graded 10-question assessment and, upon passing, issues a printable certificate of completion.
Format: Interactive e-Learning
Duration: Approximately 45 minutes
Assessment: 10-question quiz
Language: English (Global edition)
Regulatory scope: Global / ICH harmonised
What You'll Learn?
- For the individual learner:
- Taking this course removes the uncertainty of not knowing what to do when a patient or healthcare professional shares a drug safety concern. Learners gain practical, scenario-based confidence that their actions are both legally compliant and ethically sound — removing anxiety and empowering them to act decisively in real situations.
- For the organisation:
- A workforce that recognises and correctly escalates adverse events strengthens the company's pharmacovigilance system at its most critical point of failure: the moment safety information first enters the business. This directly reduces the risk of missed or late regulatory reports, which carry substantial financial penalties, regulatory sanctions, and reputational damage. Documented training completion also provides demonstrable evidence of a compliant PV culture during regulatory inspections and audits.
- For patients and public health:
- Every correctly captured and escalated adverse event report is a data point that may contribute to the detection of a new safety signal. By ensuring that all employees — not just PV specialists — understand and fulfil their reporting obligations, organisations help protect the patients who ultimately depend on the medicines they develop and market.
- Operational benefits at a glance:
- Reduces regulatory non-compliance risk, supports inspection readiness, fulfils MAH training obligations under GVP Module I, integrates directly with any LMS via SCORM 1.2, requires no facilitator or classroom resource, and delivers a consistent training experience across all geographies and functions.
- Commercial & Customer-Facing
- Medical Affairs & Clinical
- Customer & Patient Services
- Digital & Communications
- Corporate Functions
- New Joiners